Linda Ming-Huei Liau MD PhD, MBA

Brain & Spinal Tumor, Skull Base

Professor & Chair, Neurosurgery, UCLA School of Medicine

300 Stein Plaza, Suite 564Los Angeles, CA 90095
Phone+1 310-267-9449
Fax+1 310-825-9385

Dr. Liau is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Liau's full profile Already have an account?

Summary

Linda M. Liau, MD, PhD, is a Los Angeles-based neurosurgeon specializing in brain tumors and neurosurgical oncology. She completed her medical education at Stanford University, followed by a neurosurgery residency at UCLA. Dr. Liau holds a PhD in Neuroscience from UCLA and an MBA from the UCLA Anderson School of Management. She serves as a Professor and Chair at the David Geffen School of Medicine at UCLA, where she has held faculty roles since 1998. Her clinical expertise includes glioblastoma and neurosurgical oncology, and she has led several clinical trials related to brain cancer immunotherapies. Dr. Liau has authored over 250 publications on topics such as immunotherapy for gliomas, cell and gene therapies for brain tumors, and intra-operative functional brain mapping. Her accolades include election to the National Academy of Medicine and recognition as a top doctor in various prestigious listings.

Education & Training

UCLA Anderson School of ManagementMBA, Poets & Quants Best & Brightest Executive MBAs, 2014 - 2016
University of California, Los AngelesPhD, Neuroscience, 1995 - 1999
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Neurological Surgery, 1991 - 1998
Stanford University School of MedicineClass of 1991, MD
Brown UniversityBS, BA, Biochemistry, Political Science, Magna Cum Laude, 1984 - 1987

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

CA State Medical License 1993 - 2027
American Board of Neurological Surgery Neurological Surgery

Awards, Honors, & Recognition

Elected Member National Academy of Medicine, 2018
Super Doctors Southern California, 2016-2018
Top Doctors:LA Area Castle Connolly, 2013-2018

Clinical Trials

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer Start of enrollment: 2006 Dec 01
Active, not recruiting
Phase 3
Vaccine Therapy in Treating Patients With Malignant Glioma Start of enrollment: 2003 Jun 01
Completed
Phase 1
Vaccine Therapy in Treating Patients With Malignant Glioma Start of enrollment: 2006 May 01
Completed
Phase 1

Publications & Presentations

PubMed

A single-institution retrospective study of multicentric gliomas stratified bymutational status.
Chuyin Yang, Ryan Mostafavi, Collin Le, Addison Fisher, Blaine S C Eldred
Neuro-Oncology Advances. 2026-05-10
Clinical and radiographic prognostic factors in recurrent contrast-enhancing IDH-mutant gliomas treated with bevacizumab.
Collin T Le, Francesco Sanvito, Chuyin Yang, Blaine S C Eldred, Catalina Raymond
Neuro-Oncology Advances. 2026-04-06
Therapeutic efficacy of dendritic cell vaccination in a novel syngeneic mouse model of diffuse hemispheric glioma, H3 G34-mutant.
Geoffrey C Owens, Erick M Contreras, Jenny C Kienzler, Janet Treger, Horacio Soto
Journal of Neuro-Oncology. 2026-04-02

Journal Articles

Heterogeneity Within the PF-EPN-B Ependymoma Subgroup
Andrew Grossbach, Vijay Ramaswamy, Benjamin Lu, Mariarita Santi, Caterina Giannini, Linda M Liau, Terri S Armstrong, Sarah Leary, Matthias A Karajannis, Kenneth Aldape..., Acta Neuropathologica
Immunosuppressive tumor-infiltrating myeloid cells mediate adaptive immune resistance via a PD-1/PD-L1 mechanism in glioblastoma
Antonios JP, Soto H, Everson RG, Moughon D, Orpilla JR, Shin NP, Sedighim S, Treger J, Odesa S, Tucker A, Yong WH, Li G, Cloughesy TF, Liau LM, Prins RM, Neuro Oncol, 1/1/2017
Incidence, survival, pathology, and genetics of adult Latino Americans with glioblastoma
Shabihkhani M, Telesca D, Movassaghi M, Naeini YB, Hojat SA, Gupta D, Lucey GM, Ontiveros M, Wang MW, Hanna LS, Sanchez DE, Mareninov S, Khanlou N, Vinters HV, Bergsne..., J Neurooncol, 1/1/2017

Books/Book Chapters

Neurophotonics and Brain Mapping
Chapter: Spectro-Temporal Autofluorescence Contrast-Based Imaging for Brain Tumor Margin Detection and Biobanking
Page 355 - 368Papour A, Taylor Z, Liau LM, Yong WH, Stafsudd O, Grundfest WSEditors: Chen Y & Kateb B.CRC Press2017
Translational Immunotherapy for Brain Tumors
Chapter: Dendritic Cell Therapy for Brain Tumors
Everson RG, Antonios JP, Tucker AM, Liau LMEditors: Sampson JS.Elsevier, Inc2017
Intracranial Gliomas. Part III – Innovative Treatment Modalities
Chapter: Cell-Based Immunotherapy of Gliomas
Page 90 - 100Everson RG, Antonios JP, Liau LMEditors: Chernov MF, Muragaki Y, Kesari S, McCutcheon IE.Karger2017

Abstracts/Posters

Non-invasive immune monitoring following DC vaccination effectively delineates immune responses in glioblastoma
Antonios J, Soto H, Everson R,…. Liau LM, Prins RM, 21st Annual Meeting of the Society for Neuro-Oncology, Neuro-Oncol, Phoenix, AZ, 1/1/2016
Patterns from dynamic vessel size imaging of arterial and venous perfusion correlates with aggressiveness and stratifies 1p19q co-deleted from non-codeleted low-grade ...
Leu K, Cloughesy TF, Liau LM,… Ellingson B, 21st Annual Meeting of the Society for Neuro-Oncology, Neuro-Oncol, Phoenix, AZ, 1/1/2016
Simultaneous quantitative pH mapping and hypoxia imaging using fast multi-echo amine CEST-EPI in human gliomas
Harris R, Liau LM, Leu K,.... Ellingson B, 21st Annual Meeting of the Society for Neuro-Oncology, Neuro-Oncol, Phoenix, AZ, 1/1/2016

Press Mentions

5 Neurosurgeons to KnowMay 22nd, 2026
UCLA Scientists Develop One-Product-Fits-All Immunotherapy for Pancreatic CancerNovember 24th, 2025
Beating Brain Cancer Through Vaccines and ResearchNovember 20th, 2025